Health In Tech officer sells 11,667 shares at $0.92

Health In Tech’s Chief Growth Officer sold a small block of Class A Common Stock under a pre-arranged Rule 10b5-1 trading plan, leaving a direct holding of 188,544 shares.

Rhea-AI Filing Summary

Health In Tech, Inc. (HIT) disclosed that Chief Growth Officer Hasan Zain Syed sold 11,667 shares of Class A Common Stock on September 11, 2026 at a weighted average price of $0.92 per share in an open-market or private transaction. After this sale, he held 188,544 shares directly. The sale was carried out under a Rule 10b5-1 trading plan adopted on June 11, 2026, and the reported price reflects a weighted average of multiple trades between $0.9103 and $0.9541 per share.

Insider Trade Summary 10b5-1

Net Seller: 11,667 shares

Net Sell 1 txn

Insider Hasan Zain Syed

Role Chief Growth Officer

Sold 11,667 shs ($11K)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock F1, F2	11,667	$0.92	$11K

Holdings After Transaction: Class A Common Stock — 188,544 shares (Direct)

Footnotes (2)

1. F1. The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2026.
2. F2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.9103 to $0.9541 per share, inclusive. The reporting person undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Key Figures

Shares sold: 11,667 shares Weighted average sale price: $0.92 per share Post-transaction holdings: 188,544 shares +2 more

5 metrics

Shares sold 11,667 shares Class A Common Stock sold on September 11, 2026 by the Chief Growth Officer

Weighted average sale price $0.92 per share Average price for the 11,667 shares sold on September 11, 2026

Post-transaction holdings 188,544 shares Direct Class A Common Stock held by Hasan Zain Syed after the sale

Sale price range $0.9103–$0.9541 per share Range of prices for individual trades included in the weighted average

Rule 10b5-1 plan adoption date June 11, 2026 Date the trading plan governing the reported sale was adopted

Key Terms

Rule 10b5-1 trading plan, weighted average price, Class A Common Stock

3 terms

Rule 10b5-1 trading plan regulatory

"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2026."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average price financial

"The reported price in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Class A Common Stock financial

"These shares were sold in multiple transactions at prices ranging from $0.9103 to $0.9541 per share, inclusive."

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did HIT report for Chief Growth Officer Hasan Zain Syed?

HIT reported that Hasan Zain Syed sold 11,667 shares of Class A Common Stock on September 11, 2026 at a weighted average price of $0.92 per share in an open-market or private transaction.

How many HIT shares does Hasan Zain Syed hold after this reported sale?

Following the reported transaction, Hasan Zain Syed directly held 188,544 shares of Health In Tech, Inc. Class A Common Stock, as disclosed in the filing.

Was the September 11, 2026 HIT insider sale made under a Rule 10b5-1 plan?

Yes. The filing states the sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by Hasan Zain Syed on June 11, 2026.

What price did Hasan Zain Syed receive for the HIT shares sold on September 11, 2026?

The filing reports a weighted average price of $0.92 per share, with individual trades executed at prices ranging from $0.9103 to $0.9541 per share.

How many HIT shares did Hasan Zain Syed sell in the latest reported transaction?

He sold 11,667 shares of Health In Tech, Inc. Class A Common Stock in the transaction dated September 11, 2026, according to the Form 4 disclosure.

What role does Hasan Zain Syed hold at Health In Tech, Inc. (HIT)?

The filing identifies Hasan Zain Syed as the Chief Growth Officer of Health In Tech, Inc. in connection with the reported insider transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/14/2026 - 08:55 AM Accepted by SEC EDGAR 09/14/2026 - 08:55 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hasan Zain Syed

(Last) (First) (Middle)

701 S. COLORADO AVE, SUITE 1

(Street)

STUART FLORIDA 34994

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Health In Tech, Inc. [ HIT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Growth Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	09/11/2026		S		11,667(1)	D	$0.92	188,544(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2026.

2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.9103 to $0.9541 per share, inclusive. The reporting person undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

	/s/ Lori Babcock, as attorney-in-fact for Zain Hasan	09/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)